Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060397652> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W2060397652 endingPage "1209" @default.
- W2060397652 startingPage "1209" @default.
- W2060397652 abstract "We thank Drs. Seppenwoolde, Lebesque, and De Jaeger for their interest and analysis concerning our recent article (1Tsujino K. Hirota S. Endo M. et al.Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.Int J Radiat Oncol Biol Phys. 2003; 55: 110-115Abstract Full Text Full Text PDF PubMed Scopus (292) Google Scholar). In combining their data (2Seppenwoolde Y. Lebesque J.V. De Jaeger K. et al.Comparing different NTCP models that predict the incidence of radiation pneumonitis.Int J Radiat Oncol Biol Phys. 2003; 55: 724-735Abstract Full Text Full Text PDF PubMed Scopus (367) Google Scholar) on the incidence of radiation pneumonitis in patients treated with radiation alone for thoracic malignancies with our data in patients treated with concurrent chemoradiation, they clearly showed the expected additive effect of concurrent chemotherapy for radiation pneumonitis. Actually, the differences were greater than we might have imagined. We suppose that there might be an overestimating of the difference in the incidence of pneumonitis in their analyses for the following reasons. 1.Our data only include lung cancer patients, whereas Dr. Seppenwool de’s data include breast cancer and lymphoma patients, who may have better baseline pulmonary function than lung cancer patients.2.They evaluated the severity of pneumonitis in the first 6 months after treatment, whereas we evaluated at median follow-up of 7.5 months, and some pneumonitis occurred later than 6 months.3.The severity of Grade 2 pneumonitis may be different because indications for using steroids may differ among institutions and physicians. The precious estimation of the additive effect of concurrent chemotherapy on radiation pneumonitis requires larger numbers of patients who are treated and evaluated in the same manner. However, we agree with Dr. Seppenwoolde et al. that their dose–response curve shown in their letter’s Fig. 1 is extremely useful in the treatment optimization of lung cancer patients who are candidates of concurrent chemoradiation." @default.
- W2060397652 created "2016-06-24" @default.
- W2060397652 creator A5051510542 @default.
- W2060397652 date "2003-07-01" @default.
- W2060397652 modified "2023-09-27" @default.
- W2060397652 title "In response to Drs. Seppenwoolde, Lebesque, and de Jaeger" @default.
- W2060397652 cites W2036018628 @default.
- W2060397652 cites W2155422011 @default.
- W2060397652 doi "https://doi.org/10.1016/s0360-3016(03)00344-4" @default.
- W2060397652 hasPublicationYear "2003" @default.
- W2060397652 type Work @default.
- W2060397652 sameAs 2060397652 @default.
- W2060397652 citedByCount "0" @default.
- W2060397652 crossrefType "journal-article" @default.
- W2060397652 hasAuthorship W2060397652A5051510542 @default.
- W2060397652 hasBestOaLocation W20603976521 @default.
- W2060397652 hasConcept C120665830 @default.
- W2060397652 hasConcept C121332964 @default.
- W2060397652 hasConcept C121608353 @default.
- W2060397652 hasConcept C126322002 @default.
- W2060397652 hasConcept C143998085 @default.
- W2060397652 hasConcept C2776256026 @default.
- W2060397652 hasConcept C2777714996 @default.
- W2060397652 hasConcept C2779524853 @default.
- W2060397652 hasConcept C2908954928 @default.
- W2060397652 hasConcept C2989005 @default.
- W2060397652 hasConcept C509974204 @default.
- W2060397652 hasConcept C61511704 @default.
- W2060397652 hasConcept C71924100 @default.
- W2060397652 hasConceptScore W2060397652C120665830 @default.
- W2060397652 hasConceptScore W2060397652C121332964 @default.
- W2060397652 hasConceptScore W2060397652C121608353 @default.
- W2060397652 hasConceptScore W2060397652C126322002 @default.
- W2060397652 hasConceptScore W2060397652C143998085 @default.
- W2060397652 hasConceptScore W2060397652C2776256026 @default.
- W2060397652 hasConceptScore W2060397652C2777714996 @default.
- W2060397652 hasConceptScore W2060397652C2779524853 @default.
- W2060397652 hasConceptScore W2060397652C2908954928 @default.
- W2060397652 hasConceptScore W2060397652C2989005 @default.
- W2060397652 hasConceptScore W2060397652C509974204 @default.
- W2060397652 hasConceptScore W2060397652C61511704 @default.
- W2060397652 hasConceptScore W2060397652C71924100 @default.
- W2060397652 hasIssue "4" @default.
- W2060397652 hasLocation W20603976521 @default.
- W2060397652 hasOpenAccess W2060397652 @default.
- W2060397652 hasPrimaryLocation W20603976521 @default.
- W2060397652 hasRelatedWork W1866250621 @default.
- W2060397652 hasRelatedWork W1990412765 @default.
- W2060397652 hasRelatedWork W2018220333 @default.
- W2060397652 hasRelatedWork W2078081542 @default.
- W2060397652 hasRelatedWork W2133367262 @default.
- W2060397652 hasRelatedWork W2156360851 @default.
- W2060397652 hasRelatedWork W2391627076 @default.
- W2060397652 hasRelatedWork W2593609959 @default.
- W2060397652 hasRelatedWork W2622440576 @default.
- W2060397652 hasRelatedWork W4362735203 @default.
- W2060397652 hasVolume "56" @default.
- W2060397652 isParatext "false" @default.
- W2060397652 isRetracted "false" @default.
- W2060397652 magId "2060397652" @default.
- W2060397652 workType "article" @default.